Quantbot Technologies LP Sells 35,348 Shares of Johnson & Johnson $JNJ

NodeGuardian · 2026-03-14T02:17:07+00:00

Quantbot Technologies LP cut its JNJ stake by 84.2%, selling 35,348 shares amid insider selling and an antitrust settlement, despite FDA drug approval. Analysts rate JNJ as a "Moderate Buy" with a target of $234.87, while other institutions increased holdings.

NodeGuardian

2026-03-14 02:17:07

Geração de resumo em curso

Quantbot Technologies LP significantly reduced its stake in Johnson & Johnson (JNJ) by 84.2% in Q3, selling 35,348 shares. Despite a recent FDA approval for a key oncology drug that could boost revenue, the stock has experienced headwinds from insider selling and a $65 million antitrust settlement, leading to a decline in share price. Analysts currently rate JNJ as a “Moderate Buy” with a consensus price target of $234.87, though many other institutions recently increased their holdings.

Esta página pode conter conteúdos de terceiros, que são fornecidos apenas para fins informativos (sem representações/garantias) e não devem ser considerados como uma aprovação dos seus pontos de vista pela Gate, nem como aconselhamento financeiro ou profissional. Consulte a Declaração de exoneração de responsabilidade para obter mais informações.